跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVIGEN AU normal immunoglobulin (human) 5g (100g/L, 10%) solution for intravenous infusion - TGA Drug Approval Details
Approvals
/
TGA
/
PRIVIGEN AU normal immunoglobulin (human) 5g (100g/L, 10%) solution for intravenous infusion
Approved
STANDARD
PRIVIGEN AU normal immunoglobulin (human) 5g (100g/L, 10%) solution for intravenous infusion
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b84c606be0e79e23
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
b84c606be0e79e23
Product Name
PRIVIGEN AU normal immunoglobulin (human) 5g (100g/L, 10%) solution for intravenous infusion
Artg Id
328601
Artg Name
PRIVIGEN AU normal immunoglobulin (human) 5g (100g/L, 10%) solution for intravenous infusion
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2020-07-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1dd4bc273c32cad9f675ca7de59d0f48.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a7cfc972c371cd10d4378992e517f172.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b84c606be0e79e23
Type
Standard
Back to TGA Approvals